Merck & Co., Inc. (MRK)
TSX
34.86
+1.20 (+3.57%)
Closed
Aug 25, 2026
Day's Range
34.0034.90
52 wk Range
17.6634.90
Financial Statements - MRK - Merck & Co., Inc.
Revenue
65.01B▼ 25.9%
Net Income
18.26B▼ 22.1%Net Margin 28.1%
EBITDA
29.10B▼ 18.9%
Free Cash Flow
12.36B▼ 50.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 65.01B | 87.76B |
| Cost of Goods | 16.38B | 20.78B |
| Gross Profit | 48.62B | 66.98B |
 Operating Expense | - | - |
| Operating Income | 22.10B | 27.65B |
| Non-Operating Interest | - | - |
| Other Income Expense | -26M | 780.98M |
| Pre Tax Income | 21.06B | 27.26B |
| Income Tax | 2.80B | 3.83B |
| Net Income | 18.26B | 23.43B |
| EPS Basic | 1.191817 | 1.094143 |
| EPS Diluted | 1.176231 | 1.088983 |
| Basic Shares Outstanding | 15.31B | 21.39B |
| Diluted Shares Outstanding | 15.31B | 21.39B |
| Ebit | 22.42B | 29B |
| Ebitda | 29.10B | 35.87B |
| Net Income Continuous Operations | 18.26B | 23.43B |
| Minority Interests | -9M | -16M |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
